Nifty
Sensex
:
:
15778.45
52860.75
69.05 (0.44%)
207.68 (0.39%)

Pesticides & Agrochemicals

Rating :
55/99

BSE: 512070 | NSE: UPL

819.70
29-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  822.95
  •  822.95
  •  810.00
  •  814.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1839368
  •  15025.84
  •  864.70
  •  399.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 62,620.05
  • 21.81
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 81,437.05
  • 1.22%
  • 3.50

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.96%
  • 0.79%
  • 7.17%
  • FII
  • DII
  • Others
  • 37.87%
  • 15.49%
  • 10.72%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.56
  • 18.86
  • 21.01

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.88
  • 22.88
  • 17.25

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.87
  • 10.13
  • 24.19

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.76
  • 21.39
  • 20.47

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.26
  • 3.63
  • 2.92

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.91
  • 11.22
  • 10.72

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
12,796.00
11,141.00
14.86%
9,126.00
8,892.00
2.63%
8,939.00
7,817.00
14.35%
7,833.00
7,906.00
-0.92%
Expenses
10,145.00
9,237.00
9.83%
6,924.00
6,822.00
1.50%
7,272.00
6,370.00
14.16%
6,001.00
6,594.00
-8.99%
EBITDA
2,651.00
1,904.00
39.23%
2,202.00
2,070.00
6.38%
1,667.00
1,447.00
15.20%
1,832.00
1,312.00
39.63%
EBIDTM
20.72%
17.09%
24.13%
23.28%
18.65%
18.51%
14.01%
14.01%
Other Income
49.00
21.00
133.33%
67.00
52.00
28.85%
75.00
24.00
212.50%
67.00
39.00
71.79%
Interest
421.00
187.00
125.13%
745.00
515.00
44.66%
343.00
381.00
-9.97%
551.00
398.00
38.44%
Depreciation
576.00
595.00
-3.19%
542.00
495.00
9.49%
533.00
476.00
11.97%
522.00
446.00
17.04%
PBT
1,623.00
972.00
66.98%
1,060.00
1,037.00
2.22%
655.00
309.00
111.97%
801.00
435.00
84.14%
Tax
322.00
211.00
52.61%
109.00
199.00
-45.23%
112.00
99.00
13.13%
143.00
77.00
85.71%
PAT
1,301.00
761.00
70.96%
951.00
838.00
13.48%
543.00
210.00
158.57%
658.00
358.00
83.80%
PATM
10.17%
6.83%
10.42%
9.42%
6.07%
2.69%
7.11%
7.11%
EPS
13.90
8.07
72.24%
10.38
9.16
13.32%
6.05
2.17
178.80%
28.29
28.29
0.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
-
38,694.00
35,756.00
21,837.00
17,378.00
16,312.00
14,048.00
12,090.52
10,770.88
9,185.70
7,671.32
Net Sales Growth
-
8.22%
63.74%
25.66%
6.54%
16.12%
16.19%
12.25%
17.26%
19.74%
 
Cost Of Goods Sold
-
19,096.00
18,743.00
10,904.00
8,112.00
7,816.00
6,780.00
6,016.41
5,440.80
4,687.36
4,058.00
Gross Profit
-
19,598.00
17,013.00
10,933.00
9,266.00
8,496.00
7,268.00
6,074.11
5,330.08
4,498.34
3,613.32
GP Margin
-
50.65%
47.58%
50.07%
53.32%
52.08%
51.74%
50.24%
49.49%
48.97%
47.10%
Total Expenditure
-
30,343.00
28,983.00
18,068.00
13,880.00
13,331.00
11,653.00
9,826.71
8,768.16
7,551.47
6,309.48
Power & Fuel Cost
-
581.00
464.00
402.00
291.00
339.00
359.00
435.59
433.67
349.84
263.53
% Of Sales
-
1.50%
1.30%
1.84%
1.67%
2.08%
2.56%
3.60%
4.03%
3.81%
3.44%
Employee Cost
-
3,712.00
3,391.00
2,095.00
1,713.00
1,627.00
1,434.00
1,042.80
948.18
852.62
682.96
% Of Sales
-
9.59%
9.48%
9.59%
9.86%
9.97%
10.21%
8.62%
8.80%
9.28%
8.90%
Manufacturing Exp.
-
4,123.00
3,203.00
2,462.00
2,104.00
1,795.00
1,509.00
1,090.25
912.45
766.06
635.77
% Of Sales
-
10.66%
8.96%
11.27%
12.11%
11.00%
10.74%
9.02%
8.47%
8.34%
8.29%
General & Admin Exp.
-
1,807.00
2,009.00
1,379.00
1,103.00
1,036.00
888.00
723.13
622.14
520.94
423.14
% Of Sales
-
4.67%
5.62%
6.31%
6.35%
6.35%
6.32%
5.98%
5.78%
5.67%
5.52%
Selling & Distn. Exp.
-
615.00
689.00
467.00
442.00
406.00
377.00
285.18
225.50
153.55
128.62
% Of Sales
-
1.59%
1.93%
2.14%
2.54%
2.49%
2.68%
2.36%
2.09%
1.67%
1.68%
Miscellaneous Exp.
-
409.00
484.00
359.00
115.00
312.00
306.00
233.35
185.42
221.10
128.62
% Of Sales
-
1.06%
1.35%
1.64%
0.66%
1.91%
2.18%
1.93%
1.72%
2.41%
1.53%
EBITDA
-
8,351.00
6,773.00
3,769.00
3,498.00
2,981.00
2,395.00
2,263.81
2,002.72
1,634.23
1,361.84
EBITDA Margin
-
21.58%
18.94%
17.26%
20.13%
18.27%
17.05%
18.72%
18.59%
17.79%
17.75%
Other Income
-
259.00
266.00
320.00
429.00
448.00
316.00
91.11
131.35
107.37
92.33
Interest
-
2,060.00
1,643.00
998.00
791.00
735.00
704.00
517.04
485.29
428.96
414.64
Depreciation
-
2,173.00
2,012.00
881.00
675.00
672.00
676.00
424.52
406.94
353.72
292.38
PBT
-
4,377.00
3,384.00
2,210.00
2,461.00
2,022.00
1,331.00
1,413.36
1,241.84
958.92
747.15
Tax
-
686.00
586.00
198.00
275.00
189.00
165.00
244.01
221.69
203.17
128.01
Tax Rate
-
16.57%
21.22%
11.26%
11.47%
9.74%
13.73%
17.30%
19.17%
21.52%
17.57%
PAT
-
2,829.00
1,773.00
1,477.00
2,115.00
1,746.00
1,025.00
1,123.09
927.70
742.27
595.34
PAT before Minority Interest
-
3,453.00
2,175.00
1,561.00
2,123.00
1,752.00
1,037.00
1,166.36
934.85
740.71
600.69
Minority Interest
-
-624.00
-402.00
-84.00
-8.00
-6.00
-12.00
-43.27
-7.15
1.56
-5.35
PAT Margin
-
7.31%
4.96%
6.76%
12.17%
10.70%
7.30%
9.29%
8.61%
8.08%
7.76%
PAT Growth
-
59.56%
20.04%
-30.17%
21.13%
70.34%
-8.73%
21.06%
24.98%
24.68%
 
EPS
-
40.32
25.27
21.05
30.14
24.88
14.61
16.01
13.22
10.58
8.48

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
20,886.00
19,283.00
14,715.00
9,169.00
7,397.00
5,889.00
5,860.33
5,247.42
4,645.22
4,173.11
Share Capital
3,139.00
3,139.00
102.00
102.00
183.00
86.00
85.72
85.72
88.52
92.36
Total Reserves
17,747.00
16,144.00
14,613.00
9,067.00
7,212.00
2,004.00
5,774.61
5,161.70
4,556.70
4,080.75
Non-Current Liabilities
24,559.00
29,150.00
28,004.00
5,684.00
5,253.00
2,378.00
2,385.76
2,699.41
3,245.21
2,723.18
Secured Loans
0.00
0.00
2.00
3.00
4.00
7.00
8.07
9.48
17.00
62.71
Unsecured Loans
22,146.00
27,371.00
26,380.00
5,870.00
5,346.00
2,259.00
1,686.01
2,244.80
2,795.32
2,314.50
Long Term Provisions
38.00
24.00
20.00
20.00
16.00
21.00
34.13
52.98
51.40
50.84
Current Liabilities
19,627.00
16,685.00
16,262.00
7,642.00
7,028.00
8,168.00
5,993.47
4,640.15
4,198.32
3,123.03
Trade Payables
12,525.00
10,233.00
9,847.00
5,675.00
4,875.00
3,954.00
3,211.87
2,691.92
2,099.45
1,503.50
Other Current Liabilities
4,303.00
3,661.00
2,429.00
1,112.00
1,216.00
1,477.00
1,313.54
1,026.45
723.83
675.82
Short Term Borrowings
1,414.00
1,298.00
2,478.00
634.00
708.00
2,505.00
1,087.37
606.68
1,114.70
770.29
Short Term Provisions
1,385.00
1,493.00
1,508.00
221.00
229.00
232.00
380.69
315.10
260.34
173.42
Total Liabilities
68,765.00
68,430.00
62,435.00
22,514.00
19,711.00
16,479.00
14,283.92
12,759.05
12,322.98
10,269.22
Net Block
34,765.00
35,322.00
32,149.00
4,437.00
4,071.00
3,862.00
4,030.80
3,820.93
3,489.21
3,222.94
Gross Block
47,257.00
45,999.00
41,123.00
11,220.00
10,025.00
9,732.00
7,984.49
7,676.92
6,662.59
5,827.97
Accumulated Depreciation
12,492.00
10,677.00
8,974.00
6,783.00
5,954.00
5,870.00
3,953.69
3,855.99
3,173.38
2,605.03
Non Current Assets
38,695.00
39,188.00
35,713.00
7,490.00
6,013.00
5,272.00
5,795.38
5,207.51
4,885.49
4,519.18
Capital Work in Progress
2,117.00
2,073.00
1,855.00
1,319.00
792.00
484.00
583.10
227.77
377.62
305.65
Non Current Investment
581.00
558.00
706.00
1,034.00
378.00
335.00
763.63
737.28
741.45
669.52
Long Term Loans & Adv.
774.00
750.00
562.00
446.00
475.00
439.00
417.85
421.53
277.21
321.07
Other Non Current Assets
458.00
485.00
441.00
254.00
297.00
152.00
0.00
0.00
0.00
0.00
Current Assets
30,070.00
29,242.00
26,722.00
15,024.00
13,698.00
11,207.00
8,488.54
7,551.54
7,437.49
5,750.04
Current Investments
37.00
0.00
2.00
0.00
0.00
0.00
0.00
0.00
283.70
125.00
Inventories
9,422.00
7,850.00
9,133.00
4,538.00
4,156.00
3,787.00
2,937.60
2,480.07
2,068.70
1,877.86
Sundry Debtors
12,591.00
11,867.00
11,679.00
6,056.00
5,656.00
5,100.00
3,793.04
3,208.46
2,684.99
2,445.34
Cash & Bank
4,853.00
6,752.00
2,851.00
2,894.00
2,895.00
1,189.00
1,009.81
1,022.78
1,548.23
700.18
Other Current Assets
3,167.00
2,126.00
1,936.00
1,102.00
991.00
1,131.00
748.09
840.23
851.87
601.66
Short Term Loans & Adv.
1,180.00
647.00
1,121.00
434.00
410.00
759.00
585.71
750.12
779.30
528.57
Net Current Assets
10,443.00
12,557.00
10,460.00
7,382.00
6,670.00
3,039.00
2,495.07
2,911.39
3,239.17
2,627.01
Total Assets
68,765.00
68,430.00
62,435.00
22,514.00
19,711.00
16,479.00
14,283.92
12,759.05
12,322.98
10,269.22

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
7,212.00
8,739.00
2,356.00
2,839.00
2,585.00
1,396.00
1,409.02
1,440.80
1,699.23
161.96
PBT
4,181.00
2,764.00
2,210.00
2,461.00
2,022.00
1,331.00
1,418.24
1,257.39
979.10
769.32
Adjustment
3,970.00
3,744.00
1,515.00
1,010.00
923.00
1,272.00
876.13
847.04
794.62
663.54
Changes in Working Capital
-214.00
3,050.00
-564.00
-322.00
44.00
-704.00
-552.91
-397.01
104.33
-1,127.11
Cash after chg. in Working capital
7,937.00
9,558.00
3,161.00
3,149.00
2,989.00
1,899.00
1,741.46
1,707.42
1,878.05
305.75
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-725.00
-819.00
-354.00
-249.00
-341.00
-442.00
-277.76
-175.77
-143.84
-124.21
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
-4.88
-15.55
-19.94
-1.13
Extra & Other Items
0.00
0.00
-451.00
-61.00
-63.00
-61.00
-49.80
-75.30
-15.04
-18.45
Cash From Investing Activity
-2,101.00
-2,643.00
-30,920.00
-2,093.00
-999.00
-1,719.00
-331.40
-418.08
-814.71
-659.85
Net Fixed Assets
-1,021.00
-1,175.00
-1,011.00
-780.00
-427.00
-4,140.36
-531.05
-260.52
-232.66
-645.38
Net Investments
-35.00
35.00
-847.00
-1.00
-5.00
284.72
-201.57
232.90
-121.93
229.68
Others
-1,045.00
-1,503.00
-29,062.00
-1,312.00
-567.00
2,136.64
401.22
-390.46
-460.12
-244.15
Cash from Financing Activity
-6,713.00
-2,175.00
28,894.00
-801.00
140.00
469.00
-991.32
-1,680.00
-71.99
-178.20
Net Cash Inflow / Outflow
-1,602.00
3,921.00
330.00
-55.00
1,726.00
146.00
86.30
-657.28
812.53
-676.09
Opening Cash & Equivalents
6,724.00
2,826.00
2,859.00
2,877.00
1,177.00
1,046.00
1,018.36
1,685.02
822.69
1,518.49
Closing Cash & Equivalent
4,797.00
6,724.00
2,827.00
2,859.00
2,880.00
1,177.00
973.46
1,018.36
1,685.02
822.69

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
233.99
213.03
192.35
119.86
96.54
32.40
91.15
81.62
69.97
60.24
ROA
5.03%
3.32%
3.68%
10.06%
9.68%
6.74%
8.63%
7.45%
6.56%
6.51%
ROE
20.19%
14.03%
13.07%
25.76%
37.26%
26.09%
21.00%
18.90%
16.80%
15.21%
ROCE
13.40%
9.59%
9.24%
21.57%
21.49%
18.79%
21.73%
18.82%
16.73%
16.37%
Fixed Asset Turnover
0.98
0.96
0.98
2.01
1.69
1.62
1.54
1.50
1.47
1.49
Receivable days
97.92
102.45
125.56
100.30
117.68
113.15
105.68
99.86
101.93
93.37
Inventory Days
69.15
73.90
96.79
74.46
86.91
85.56
81.78
77.07
78.41
78.11
Payable days
132.56
132.02
140.15
141.01
123.97
112.79
110.01
100.69
90.37
73.75
Cash Conversion Cycle
34.51
44.33
82.21
33.75
80.62
85.92
77.46
76.24
89.96
97.73
Total Debt/Equity
1.13
1.49
1.98
0.72
0.86
2.52
0.56
0.64
0.90
0.81
Interest Cover
3.01
2.68
2.76
4.03
3.64
2.71
3.73
3.38
3.20
2.76

News Update:


  • UPL launches new ‘NPP’ business unit
    29th Jun 2021, 13:35 PM

    NPP will act as a stand-alone brand

    Read More
  • UPL partnering with Austrian company Pixofarm GmbH
    22nd Jun 2021, 14:11 PM

    Pixofarm and UPL will work together to expand grower access to Pixofarm’s technology to help improve efficiency, productivity, and sustainability of fruit farms

    Read More
  • UPL bags prestigious Asian Sustainability Leadership Award
    14th Jun 2021, 10:02 AM

    UPL has showcased its commitment to sustainability via numerous initiatives and programs

    Read More
  • UPL sets up oxygen plants at 8 hospitals in four states
    29th May 2021, 09:00 AM

    The company has converted four of its nitrogen plants in Gujarat to produce and deliver oxygen

    Read More
  • UPL reports 72% rise in Q4 consolidated net profit
    14th May 2021, 11:31 AM

    Total income of the company increased by 15.08% at Rs 12845 crore for Q4FY21

    Read More
  • UPL’s arm enters into license agreement with Meiji Seika Pharma
    11th May 2021, 11:22 AM

    Together, both companies will continue their contributions to the development of differentiated solutions based on Flupyrimin to address farmer pain points and improve their livelihoods

    Read More
  • UPL planning to supply oxygen to 4 hospitals in Gujarat, Madhya Pradesh
    24th Apr 2021, 10:57 AM

    The company is planning to produce oxygen from four of its nitrogen- producing plants in Gujarat for four hospitals in Gujarat and Madhya Pradesh amid rising cases of COVID-19

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.